Log in to save to my catalogue

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7426596

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

About this item

Full title

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2020-08, Vol.5 (1), p.156-156, Article 156

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The global Coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has affected more than eight million people. There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patients. In this study, we profiled adaptive immune cells of PBMCs from recovered COVID-19 patients with varying disease severity using...

Alternative Titles

Full title

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7426596

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7426596

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-020-00263-y

How to access this item